Grandfield & Dodd, LLC Novartis Ag Transaction History

Grandfield & Dodd, LLC

  • $1.58 Billion
  • Q3 2024

A detailed history of Grandfield & Dodd, LLC transactions in Novartis Ag stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 162,363 shares of NVS stock, worth $15.8 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
162,363
Previous 160,542 1.13%
Holding current value
$15.8 Million
Previous $17.1 Million 9.26%
% of portfolio
1.18%
Previous 1.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$106.13 - $120.89 $193,262 - $220,140
1,821 Added 1.13%
162,363 $18.7 Million
Q2 2024

Aug 09, 2024
BUY
$92.57 - $107.37 $72,019 - $83,533
778 Added 0.49%
160,542 $17.1 Million
Q1 2024

May 03, 2024
BUY
$95.27 - $108.47 $165,102 - $187,978
1,733 Added 1.1%
159,764 $15.5 Million
Q4 2023

Jan 31, 2024
BUY
$92.27 - $101.54 $277,271 - $305,127
3,005 Added 1.94%
158,031 $16 Million
Q3 2023

Oct 25, 2023
BUY
$94.73 - $105.13 $120,212 - $133,409
1,269 Added 0.83%
155,026 $15.8 Million
Q2 2023

Aug 07, 2023
BUY
$92.52 - $104.91 $14,433 - $16,365
156 Added 0.1%
153,757 $15.5 Million
Q1 2023

Apr 28, 2023
BUY
$80.03 - $92.81 $123,086 - $142,741
1,538 Added 1.01%
153,601 $14.1 Million
Q4 2022

Jan 20, 2023
BUY
$75.55 - $92.52 $971,573 - $1.19 Million
12,860 Added 9.24%
152,063 $0
Q3 2022

Nov 03, 2022
BUY
$74.61 - $87.26 $129,373 - $151,308
1,734 Added 1.26%
139,203 $10.6 Million
Q2 2022

Aug 01, 2022
BUY
$80.52 - $93.75 $274,090 - $319,125
3,404 Added 2.54%
137,469 $11.6 Million
Q1 2022

Apr 19, 2022
BUY
$80.11 - $90.62 $358,892 - $405,977
4,480 Added 3.46%
134,065 $11.8 Million
Q4 2021

Feb 08, 2022
BUY
$79.7 - $88.13 $314,018 - $347,232
3,940 Added 3.14%
129,585 $11.3 Million
Q3 2021

Oct 28, 2021
SELL
$81.78 - $95.14 $596,503 - $693,951
-7,294 Reduced 5.49%
125,645 $10.3 Million
Q2 2021

Jul 28, 2021
BUY
$85.24 - $94.15 $325,957 - $360,029
3,824 Added 2.96%
132,939 $12.1 Million
Q1 2021

Apr 22, 2021
SELL
$83.5 - $98.47 $183,950 - $216,929
-2,203 Reduced 1.68%
129,115 $11 Million
Q4 2020

Jan 29, 2021
SELL
$78.07 - $94.43 $45,280 - $54,769
-580 Reduced 0.44%
131,318 $12.4 Million
Q3 2020

Nov 03, 2020
BUY
$82.14 - $91.0 $186,457 - $206,570
2,270 Added 1.75%
131,898 $11.5 Million
Q2 2020

Jul 24, 2020
BUY
$80.93 - $91.1 $48,962 - $55,115
605 Added 0.47%
129,628 $11.3 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $140,279 - $196,534
1,985 Added 1.56%
129,023 $10.6 Million
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $141,708 - $160,221
1,680 Added 1.34%
127,038 $12 Million
Q3 2019

Oct 30, 2019
BUY
$85.54 - $94.26 $171,507 - $188,991
2,005 Added 1.63%
125,358 $10.9 Million
Q2 2019

Jul 29, 2019
BUY
$75.4 - $92.8 $14,476 - $17,817
192 Added 0.16%
123,353 $11.3 Million
Q1 2019

Apr 26, 2019
SELL
$75.32 - $86.15 $75,320 - $86,150
-1,000 Reduced 0.81%
123,161 $11.8 Million
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $18,046 - $20,094
-245 Reduced 0.2%
124,161 $10.7 Million
Q3 2018

Nov 02, 2018
BUY
$66.94 - $77.43 $116,743 - $135,037
1,744 Added 1.42%
124,406 $10.7 Million
Q2 2018

Jul 27, 2018
BUY
$64.91 - $73.36 $104,505 - $118,109
1,610 Added 1.33%
122,662 $9.27 Million
Q1 2018

May 04, 2018
BUY
$70.39 - $84.15 $218,560 - $261,285
3,105 Added 2.63%
121,052 $9.79 Million
Q4 2017

Feb 06, 2018
BUY
$72.33 - $77.64 $339,951 - $364,908
4,700 Added 4.15%
117,947 $9.9 Million
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $8.4 Million - $8.75 Million
113,247
113,247 $9.72 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Grandfield & Dodd, LLC Portfolio

Follow Grandfield & Dodd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email